Low-Dose Olanzapine Effectively Reduces chemotherapy induced vomiting in Cancer Patients

A recent study discovered that a lower dose of Olanzapine (OLZ) is just as effective as the standard dose for chemotherapy-induced nausea and vomiting (CINV), while it also significantly reduced daytime somnolence in cancer patients, The outcomes were presented in San Antonio Breast Cancer Symposium 2023.

CINV poses a significant burden on cancer patients undergoing highly emetogenic chemotherapy (HEC). The standard 10 mg dose of Olanzapine, when combined with triple antiemetics (TAE), has demonstrated it’s efficacy. However, the accompanying daytime somnolence has limited its widespread use. This prompted researchers to explore the potential of a lower dose of OLZ in conjunction with a single dose of steroids.

The randomized study included patients with solid tumors slated for anthracycline-cyclophosphamide and high-dose cisplatin chemotherapy. Patients were divided into two groups as one receiving the standard 10mg OLZ (standard arm) and the other receiving a reduced 2.5mg dose (experimental arm) with TAE. Evaluating the Complete Control Rate (CCR), including the absence of emetic episodes, no use of rescue medications, and no or mild nausea were the primary objective.

The study comprised a total of 267 analyzable subjects who demonstrated that the 2.5mg dose was non-inferior to the 10mg dose in controlling CINV without the need for delayed steroids. The CCR in the overall phase was comparable between the two groups (44.7% vs. 43.7%). Also, the lower dose significantly reduced daytime somnolence, with 65.2% in the 2.5mg group compared to 89.6% in the 10mg group (p < 0.001).

The outcomes of this study conclude that a low dose of 2.5mg Olanzapine is effective as the standard 10mg dose in controlling CINV during highly emetogenic chemotherapy. Also, the reduced dosage regimen shows superiority in reducing daytime somnolence and offers an effective alternative for cancer patients. 

Source:

Bajpai J, Kapu V, Rath S, et al. A randomized, open-label phase III trial evaluating low- dose vs standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy- induced nausea and vomiting in solid tumors (OLAnzaPiNE). Presented at SABCS 2023. December 5-9, 2023. San Antonio, TX. Abstract RF01-08

Powered by WPeMatico

Thiazolidinediones use reduces risk of rheumatoid arthritis in type 2 diabetes patients

China: A study published in Arthritis Care & Research by a team led by Houyu Zhao, PhD from the School of Public Health, Peking University, concluded that T2DM patients who use thiazolidinediones have a lower risk of developing rheumatoid arthritis.

Thiazolidinediones (TZDs) have demonstrated a potential protective effect against rheumatoid arthritis (RA) in preclinical studies. However, there needs to be more evidence from population-based studies.

This retrospective cohort study aimed to evaluate the relationship between TZD usage and RA incidence in patients with type 2 diabetes mellitus (T2DM).

Researchers assembled a retrospective cohort of T2DM patients who were recent users of TZDs or alpha-glucosidase inhibitors (AGIs). Using an IPTW Cox model, they estimated the HR of RA incidence associated with TZD use compared to AGIs.

The study included 56,796 new users of AGIs and 14,892 new users of TZDs. The incidence of RA was 187.4 and 135.2 per 100,000 person-years in AGI and TZD users, respectively. TZD use was associated with a lower RA incidence than AGI use, with an HR of 0.72. HRs for cumulative TZD use of 0.51-4.0 years and > four years were 0.55 and 0.74, respectively. Subgroup and sensitivity analyses supported the primary analysis.

The co-author, Xiaowei Chen BS from the Department of Epidemiology and Biostatistics, said that in our study, we found the use of thiazolidinediones to be linked to reduced incidence of Rheumatoid arthritis in type 2 diabetes patients.

Reference:

Zhao, H., Chen, X., Sun, Y., Shen, P., Lin, H., Sun, F., & Zhan, S. (2023). Associations between thiazolidinediones use and incidence of rheumatoid arthritis: A retrospective population‐based cohort study. Arthritis Care & Research. https://doi.org/10.1002/acr.25277

Powered by WPeMatico

No need to panic, need to remain alert: AIIMS on new COVID subvariant JN.1

After a surge in the cases of the new COVID subvariant JN.1, doctors from the All India Institute of Medical Sciences (AIIMS) have advised people to not panic but rather remain alert and vigilant.

“People are getting infected by the new sub-variant of COVID-JN.1 in many states of the country. The symptoms of the patients are mild. Therefore, there is no need to panic but the need to remain alert,” Doctor Neeraj Nischal said.

For more details, check out the link given below:

COVID Subvariant JN.1: AIIMS Delhi Advises Not To Panic, Need To Remain Alert

Powered by WPeMatico

Violence: Doctor of Forensic Science department at GSVM Medical College gets brutally attacked by group of miscreants, three arrested

Kanpur: In a shocking incident, a doctor of the Forensic Science Department at GSVM Medical College in Kanpur was subjected to an alleged brutal attack by a group of miscreants after his car collided with the miscreant’s vehicle near the Swaroop Nagar area of the city. 

The doctor sustained severe injuries to his head and right eye and was promptly admitted to Halat Hospital for urgent medical care. Presently, the doctor’s condition remains unknown.

Three miscreants have been arrested so far by the police after a complaint was filed by the doctor at Swaroop Nagar police station. 

The disturbing incident unfolded on Saturday night when the miscreants violently assaulted the doctor named Dr Piyush Gangwar. The sequence of events began when Dr Gangwar’s car collided with another vehicle near the Swaroop Nagar police station. 

Also read- Resident Doctor Safdarjung Hospital Gets Brutally Attacked By Pet Dog, FIR Registered Against Owner

The accused asked the doctor to stop the car as he was passing through the Swaroop Nagar police station. Nevertheless, Piyush Gangwar proceeded to drive his vehicle towards the medical college. Following this, a group of five to six accused from the other vehicle chased his car, forcibly pulled him out of his car and brutally attacked him, Dainik Bhaskar reports.

In an attempt to escape the assault, Dr Piyush managed to reach the safety of the medical college premises. However, the assailants allegedly followed him into the campus, escalating the violence. The commotion drew the attention of other doctors, staff, and students at the medical college.

Responding to the screams and chaos, the medical college community intervened to rescue Dr Piyush. The doctors retaliated against the attackers, resulting in a severe beating for the accused. The enraged students also vandalized the assailants’ car during the incident.

To avoid further harm, the attackers sought refuge at the Swaroop Nagar police station where they described their side of the incident. Moments later, the doctor clarified the incident to the police and filed a complaint against the miscreants. 

Based on Dr Piyush’s complaint, the police registered a case against the unidentified group of 5-6 people. Following identification, the police filed a case specifically against three assailants—Jitendra Sharma, Udit Singh, and Pratham Sharma. Subsequently, these three accused have been arrested. 

As a consequence of the incident, four individuals got injured on both sides and were admitted to Halat Hospital.

Giving details of the incident, Swaroop Nagar Assistant Commissioner of Police, Shikhar told ETV Bharat “A doctor was struck by a car in front of the Medical College Gate in the Swaroop Nagar police station area on Saturday night and was also beaten up by the individuals. A case has been filed under the relevant sections based on the complaint, and three accused have also been taken into custody.”

Also read- Patna: Surgeon Brutally Assaulted After Patient Death, IMA Bihar Goes On State Wide Strike

Powered by WPeMatico

NEXT now Mandatory after BAMS, BSMS, BUMS courses Regulations released

New Delhi: After MBBS and BDS, the National Exit Test (NExT) has also been mandatory for AYUSH courses. This has been confirmed in the newly introduced National Commission for Indian System of Medicine (National Examinations for Indian System of Medicine) Regulations, 2023, which were published in the Gazette notification dated 20.12.2023.

The AYUSH NExT will be held for Ayurveda, Siddha, Unani, and SowaRigpa courses, and without passing the exam, any graduate of Bachelor of Ayurvedic Medicine and Surgery or Bachelor of Unani Medicine and Surgery or Bachelor of Siddha Medicine and Surgery or Bachelor of SowaRigpa Medicine and Surgery, shall not be eligible for enrollment in the State Register or National Register, mentioned the Gazette notification.

As per the Gazette, the NExT exam for the AYUSH courses shall be conducted ordinarily in February and August of every year. However, following the pattern of MBBS and BDS courses, NExT is not going to replace the postgraduate entrance examination for the Ayush PG courses.

It has been mentioned in the notification that an All India Ayush Post-Graduate Entrance Test including aptitude test for respective disciplines of Indian Systems of Medicine shall be conducted by the designated authorities. The PG entrance exam for the AYUSH courses shall ordinarily be conducted in April every year or on the date specified by the Commission for that academic year.

The NCISM Regulations, 2023, have come into force on the date of their publication in the official Gazette i.e. 20.12.2023. The National Commission for the Indian System of Medicine has made these regulations in exercise of the powers conferred by sub-section (1) and clause (h) (i) (j) (k) (l) (m) (n) (o) of sub-section (2) of section 55 of the National Commission for Indian System of Medicine Act, 2020.

National Exit Test (NExT) for AYUSH:

According to the Gazette notification, a National Exit Test of each discipline such as Ayurveda, Siddha, Unani and SowaRigpa of the Indian System of Medicine shall be conducted by the Commission through a designated authority.

It further mentioned that the NExT exam for AYUSH shall be held for granting license to practice as medical practitioner of respective discipline of the Indian System of Medicine and to get enrolled in the State Register or National Register as a registered medical practitioner of the Indian System of Medicine after completing the one-year internship.

“The examination shall be problem based to test the clinical competency, understanding of medical ethics and the ability to deal with medico-legal cases as a medical practitioner in the discipline Ayurveda, Unani, Siddha and Sowa-Rigpa, as the case may be,” mentioned the Gazette. Further, it mentioned that the NExT exam shall be conducted ordinarily in the month of February and August of every year.

Eligibility to Appear in the National Exit Test: 

As per the Gazette, the eligibility to appear in the National Exit Test shall be as under:

(a) an intern who has completed minimum two hundred and seventy days of internship as on closing date of the submission of the application for National Exit Test; or

(b) graduates of Ayurveda, Siddha, Unani and Sowa-Rigpa who have completed one-year compulsory internship; or (c) Foreign nationals whose medical qualification has been recognized under section 36 of the Act.

The Gazette notification clarified that “Without qualifying National Exit Test, any graduate of Bachelor of Ayurvedic Medicine and Surgery or Bachelor of Unani Medicine and Surgery or Bachelor of Siddha Medicine and Surgery or Bachelor of SowaRigpa Medicine and Surgery, shall not be eligible for enrollment in the State Register or National Register, as the case may be.”

There shall not be any limit for attempts to appear in the National Exit Test and the candidates, securing fifty percent and above shall be declared as qualified in the National Exit Test and the list of qualified candidates shall be displayed on the website of the Commission.

Following this, the qualified candidates shall be eligible to get registered as medical practitioners only after completing the one-year compulsory rotatory internship subject to the fulfillment of the criteria specified by the Board of Ethics and Registration for Indian System of Medicine.

The Gazette mentioned that the graduation degree of the candidate who could not qualify the National Exit Test, shall be considered for all other job opportunities and other educational programs or courses where medical registration is not mandatory.

“Qualifying in National Exit Test and getting enrolled in a State Register and National Register, as the case may be, shall be the essential requirement for practicing as a registered medical practitioner or for any job where clinical work is involved or for any job where medical registration is mandatory or to pursue post graduate course in Ayurveda, Siddha, Unani and Sowa-Rigpa,” stated the notification.

According to the Gazette, the Technical Committee for the NExT shall consist of-

(i) Controller of Examinations – Chairperson;

(ii) Nominee from designated agency – Member;

(iii) Member, Board of Ayurveda – Member;

(iv) Member, Board of Unani, Siddha and Sowa-Rigpa – Member;

(v) Member, Board of Ethics and Registration for Indian system of Medicine – Member;

(vi) Four Experts – one each from Ayurveda, Siddha, Unani and Sowa-Rigpa– Member;

(vii) Health Education Technologist – Member; and

(viii) Deputy Controller of Examinations – Member Secretary.

Terms of reference:

(i) the term of the committee shall be for four successive examinations or re-constitution of the committee by the Commission, whichever is earlier;

(ii) the Committee shall meet as required;

(iii) the Committee can co-opt any expert member as per the requirement and with the approval of the President, Board of Ayurveda or President, Board of Unani, Siddha and Sowa-Rigpa, as the case may be;

(iv) the Committee shall specify the syllabus and develop the ‘blue print’ of the question paper for every examination; (v) the Committee shall identify experts and moderators for question paper setting;

(vi) the Committee shall coordinate with the assigned agency for conducting examination;

(vii) the committee prepare required information brochure and guidelines; and

(viii) the Committee shall ensure the confidentiality of the matters connected with the examinations.

National Eligibility-Cum-Entrance Test for Ayurveda, Unani and Siddha:

The notification mentioned that the National Eligibility-cum-Entrance Test for admission in undergraduate courses of Ayurveda, Siddha and Unani (ASU) shall be conducted in each academic year by the National Commission for Indian System of Medicine through the National Testing Agency or by any other agency designated by the Commission.

Eligibility Criteria:

The eligibility criteria for appearing National Eligibility-cum-Entrance Test examination and admission in undergraduate courses of Ayurveda, Unani and Siddha shall be, as specified in regulation National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Ayurveda Education) Regulations, 2022, the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Unani Education) Regulations, 2022 and the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Siddha Education) Regulations, 2022 respectively.

Further, the Gazette mentioned that the process of counseling and admissions to undergraduate courses of Ayurveda, Unani and Siddha shall be as per the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Ayurveda Education) Regulations, 2022, the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Unani Education) Regulations, 2022 and the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Siddha Education) Regulations, 2022 and the guidelines issued by the Commission from time to time.

National Eligibility-cum-Entrance Test to Sowa-Rigpa:

As per the Gazette notification, the Commission shall conduct an independent National Eligibility-cum-Entrance Test to undergraduate course of Sowa-Rigpa. This entrance test shall be conducted every year through designated authority or agency or institute for the admission to the undergraduate course of Sowa-Rigpa in all SowaRigpa institutions. The examination shall be conducted offline or the mode as specified by the Commission from time to time. 

Eligibility Criteria: 

The eligibility criteria for appearing National Eligibility-cum-Entrance Test for Sowa-Rigpa and admission to undergraduate courses of Sowa-Rigpa institution shall be as specified in the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Sowa-Rigpa Education) Regulations, 2022.

“An All-India common merit list of the eligible candidates shall be prepared on the basis of the marks obtained in National Eligibility-cum- Entrance Test for Sowa-Rigpa and the qualified candidates shall be considered for admission to undergraduate course as specified in the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Sowa-Rigpa Education) Regulations, 2022 and such merit list shall be applicable for that particular academic session only,” mentioned the Gazette.

It further added that the process of counselling and admissions in the undergraduate courses of Sowa-Rigpa shall be as per the National Commission for Indian System of Medicine (Minimum Standards of Undergraduate Sowa-Rigpa Education) Regulations, 2022 and admission guidelines issued by the Commission from time to time.

As per the Gazette, the institution of Sowa-Rigpa shall submit the details of admitted students as per the Appendix-V of the Regulations or as may be specified by the Commission, on or before cut-off date for admission into Sowa-Rigpa institution for verification.

Technical Committee for National Eligibility-cum-Entrance Test for Sowa-Rigpa:

The panel shall consist of-

(i) Controller of Examinations – Chairperson;

(ii) Nominee from designated agency as Director, National Eligibility-cum-Entrance Test for SowaRigpa – Member;

(iii) Nominee from designated agency as Chief Co-ordinator, National Eligibility-cum-Entrance Test for Sowa-Rigpa – Member;

(iv) Member, Board of Unani, Siddha and Sowa-Rigpa – Member;

(v) Member, Medical Assessment and Rating Board for Indian System of Medicine – Member;

(vi) Three Experts of Sowa-Rigpa system – Member; and (vii) Deputy Controller of Examinations – Member Secretary 

Terms of reference:

(i) the term of the committee shall be for two successive examinations or re-constitution of the committee by the Commission, whichever is earlier;

(ii) the Committee shall meet as required;

(iii) the Committee can co-opt any expert member as per the requirement and with the approval of the President, Board of Unani, Siddha and Sowa-Rigpa;

(iv) the Committee shall specify the syllabus and develop a ‘blue print’ of the question paper for every examination;

(v) the committee shall prepare the schedule of entire examination events;

(vi) the committee shall prepare the list of chief superintendent of exam centres, National Commission for Indian System of Medicine observers, experts and moderators for question paper setting and evaluators for evaluating answer scripts;

(vii) the Committee shall coordinate with the assigned agency for conducting examination;

(viii) the committee shall prepare information brochure and examination-counselling-admission guidelines; and

(ix) the Committee shall ensure the confidentiality of the matters connected with the examinations.

All India Ayush Post-Graduate Entrance Test:

Unlike MBBS and BDS courses, NExT exam is not going to replace the Postgraduate entrance examination for AYUSH courses as well. As per the Gazette, the Post-Graduate National Entrance Test as specified in the Act, is also known as All India Ayush Post-Graduate Entrance Test.

The All India Ayush Post-Graduate Entrance Test including aptitude test for respective disciplines of Indian Systems of Medicine shall be conducted by the designated authority. Ordinarily, the All India Ayush Post-Graduate Entrance Test shall be conducted in the month of April every year or on the date as specified by the Commission for that academic year.

Eligibility Criteria: 

Undergraduate Degree holders such as Bachelor of Ayurvedic Medicine and Surgery, Bachelor of Unani Medicine and Surgery and Bachelor of Siddha Medicine and Surgery who have completed their internship by 30th of April or as specified by National Commission for Indian System of Medicine from time to time shall be eligible for appearing All India Ayush Post-Graduate Entrance Test.

Further, the Gazette mentioned that at the time of admission, the candidate shall have enrolled or registered as a medical practitioner in State Register or Union Territory Register or National Register, as the case may be.

Results and Counselling: 

All India Ayush Postgraduate Entrance Test results shall be declared separately for each discipline such as Ayurveda, Siddha and Unani by the designated authority and the results thus declared shall be valid for that academic year only.

Regarding the process of counselling, the Gazette mentioned that the counselling and admissions to the PG courses of Ayurveda, Siddha and Unani shall be as per the guidelines specified by the Commission from time to time.

Technical Committee for All India Ayush Post-Graduate Entrance Test:

The panel shall consist of-

(i) Controller of Examinations – Chairperson;

(ii) Nominee from designated agency – Member;

(iii) Member, Board of Ayurveda – Member;

(iv) Member, Board of Siddha, Unani and Sowa-Rigpa – Member;

(v) Member, Medical Assessment and Rating Board for Indian System of Medicine – Member;

(vi) Health Education Technologist – Member;

(vii) Three Experts – one each from Ayurveda, Siddha and Unani – Member; and

(viii) Deputy Controller of Examinations – Member Secretary.

Terms of reference:

(i) the term of the committee shall be for two successive examinations or re-constitution of the committee by the Commission, whichever is earlier;

(ii) the Committee shall meet as required;

(iii) the Committee can co-opt any expert member as per the requirement and with the approval of the President, Board of Ayurveda or President, Board of Unani, Siddha and Sowa-Rigpa, as the case may be ;

(iv) the Committee shall specify the syllabus and develop a ‘blue print’ of the question paper for every examination;

(v) the Committee shall identify experts and moderators for question paper setting;

(vi) the Committee shall coordinate with the assigned agency for conducting examination;

(vii) the committee shall prepare required information brochures and guidelines; and

(viii) the Committee shall ensure the confidentiality of the matters connected with the examinations

Also Read: Soon: NExT exam for BDS, Bill Introduced in Parliament

Powered by WPeMatico

Health Bulletin 25/December/2023

Here are the top health stories for the day:

“No need to panic, need to remain alert”: AIIMS on new COVID subvariant JN.1

After a surge in the cases of the new COVID subvariant JN.1, doctors from the All India Institute of Medical Sciences (AIIMS) have advised people to not panic but rather remain alert and vigilant.

“People are getting infected by the new sub-variant of COVID-JN.1 in many states of the country. The symptoms of the patients are mild. Therefore, there is no need to panic but the need to remain alert,” Doctor Neeraj Nischal said.

For more details, check out the link given below:

COVID Subvariant JN.1: AIIMS Delhi Advises Not To Panic, Need To Remain Alert

Disclosure of assets of members: NMC expresses its reservations to Health Ministry

Amid the rising pressure to make the details of the assets and liabilities of the NMC Chairman and members public, the National Medical Commission (NMC) has expressed its ‘reservations’ in this regard.

Writing to the Under Secretary of the Union Ministry of Health and Family Welfare (MoHFW), the Commission has mentioned about the reservations for uploading some of the personal information of the officers including the details of lands, jewellery, investments in banks/ financial institutions/ insurance policy i.e. numbers, addresses etc.

For more details, check out the link given below:

Disclosure Of Assets Of Members: NMC Expresses Its Reservations To Health Ministry

Chinese doctor suspended for punching patient during surgery

Chinese authorities are investigating an incident where a surgeon is alleged to have punched a patient during an operation, as shown in a viral video without a specified date. The hospital’s parent company, Aier China, has suspended the surgeon, and the hospital’s CEO, where the 2019 incident occurred, has also been dismissed. The video appears to depict the surgeon, performing eye surgery, punching the patient’s head multiple times, with two others present in the operating room.

Aier China operates a chain of eye hospitals, confirmed the incident at its Guigang hospital, involving an 82-year-old woman who experienced discomfort during surgery due to local anesthesia. The patient, who spoke a local dialect, reportedly did not respond to warnings in Mandarin, leading the surgeon to act roughly in what was described as an emergency situation. Local authorities noted injuries to the patient’s forehead.

Powered by WPeMatico

MUHS announces surprise inspection of nursing colleges January 2024 onwards

Maharashtra: The surprise inspection will commence from 22.01.2024 onwards for the grant of Continuation/Extension of Affiliation for Academic Year 2024-25 for nursing faculty, a recent notice by the  Maharashtra University of Health Sciences (MUHS) to all the nursing colleges has informed 

The MUHS has also issued detailed guidelines related to the same.

“The University has initiated the process of Continuation of Affiliation/ Extension of Affiliation (if applicable) of affiliated Colleges for Academic Year 2024-25. Accordingly, the University has finalized the Local Inquiry Committee (LIC) Proforma for inspections,” the notice stated

The Colleges are required to go through LICIs Inspection Proforma and shall fill up requisite information, including all Annexures, for verification of the LIC Team. As instructed earlier during inspections for A.Y.2023-24, the Colleges have created the “MUHS Mandate” tab on the homepage of the College Website. It is mandatory for Colleges to upload information on all Annexures on the college website, and the information should be kept Year-wise and Annexures-wise for a period of 05 years.

MUHS further informed that the University has taken up paperless initiative and is gearing up for the Online Transmission of Question Papers and Onscreen Evaluation of Answer Books. However, the college must submit hard copies of a few annexures, viz. Annexures I, VI, VII, VIII & XIV to the University. Copies of the rest of the Annexures must be uploaded on the respective College Website.

It is mandatory for the College to maintain infrastructure, teaching staff, and other requirements as per MSR throughout the year; failing which affiliation granted shall be revoked by the University at any stage.

The Dean / Principal of the nursing College is required to update the College website as well as keep the information ready for verification of the LIC Team, the notice added

The pro-forma for the same can be checked out in the official notice. 

To view the notice, click on the link below –

https://medicaldialogues.in/pdf_upload/circular-no-742023-lic-insp-202425221223-228610.pdf

Powered by WPeMatico

Intas Pharma gets exclusive rights to commercialize Etanercept biosimilars in more than 150 countries across globe

Ahmedabad: Intas Pharmaceuticals Ltd., a multinational pharmaceutical company, has announced a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma) for a biosimilar for Etanercept.

Etanercept is a dimeric fusion protein with tumor necrosis factor (TNF) blocking action that was approved for use over 20 years ago, offering patients a valuable therapeutic option for treating various autoimmune diseases. According to IQVIA, global sales of Etanercept for 12 months, ending June 2023, were $ 11B.

In the partnership arrangement, Intas receives exclusive rights to commercialize Etanercept biosimilars, through its affiliates, for the treatment of various autoimmune diseases, in more than 150 countries across the globe, including Europe and the United States of America, leveraging strong sales, marketing capabilities and experience in successfully commercializing new biosimilars. mAbxience will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar from its state-of-the-art, Good Manufacturing Practices (GMP) approved facilities.

“Partnering up with mAbxience, who are known for their dedication to quality and innovation, aligns perfectly with our vision. This partnership enables us to achieve our goal of providing high-quality treatments to patients worldwide. Together, we aim to revolutionize the landscape of autoimmune disease treatment,” said Intas’ Vice Chairman, Mr. Binish Chudgar.

Paul Tredwell, Executive Vice President of EMENA, Accord, said, “Accord is delighted to partner with mAbxience, whom we have known for some time as an excellent partner. This partnership cements our commitment to our autoimmune franchise, building on our innovative range of methotrexate products. Etanercept is a key biologic treatment which will continue to support patients. This, along with our future biological launches significantly increases our presence in our growing autoimmune franchise.”

“Expanding our global reach has always been at the core of mAbxience’s vision. Collaborating with Intas allows us to tap into new markets and bring our cutting-edge biosimilar candidate to countless patients battling autoimmune diseases. It reinforces our dedication to leading the way in the biosimilar industry,” said Jurgen Van Broeck, Global Commercial Director, mAbxience.

The financial terms of the transaction remain confidential. 

Read also: Intas Pharma to commercialise Serplulimab in India

Powered by WPeMatico

DME Gujarat Asks NEET Candidates To Fill Bank Account Details For Refund Process

Gujarat: The Director of Medical Education (DME Gujarat) has asked the NEET UG candidates to fill in the bank account details who have not received the refund. The list of unsuccessful tuition fee refund and security deposit refund candidates list of round 3, and the list of successful candidates whose tuition fee and security deposit have been refunded for rounds 1, 2, and 3 have also been released.

As per the notice, Students who have taken admission in Bachelor Medical/Dental/Ayurveda/Homeopathy (up to 9th round) in 2023-24 and have not received tuition fee refund in refund round 1, refund round 2 and refund round 3 should fill their bank account details. Further, students who are eligible for a refund of Rs.10,000/- security deposit and have not received refund round 1, refund round 2 and refund round 3 deposits have to fill in their bank account details. 

Instructions for refund –

For tuition fee refund – The candidates who have been admitted in Medical/Dental/Ayurved/Homoeopathy (till 9th Round only) and are eligible for the refund from the tuition fee paid at ACPUGMEC will have to fill in the online details at the link mentioned in the notice below regarding their refund, Bank Name; Bank Account No.; Bank MICR No.; IFSC No.; Account Holder Name.

For security deposit refund – The candidates who have either admitted/Non-admitted in Medical/Dental/Ayurved/Homoeopathy and are eligible for the refund of Security Deposit at ACPUGMEC will have to fill in the online details at the link mentioned in the notice below regarding their refund, Bank Name; Bank Account No.; Bank MICR No.; IFSC No.; Account Holder Name.

For NRI Candidates – For the refund of fees paid at ACPUGMEC, the NRI Candidates have to fill in the details of the Indian Account. Do not fill in the details of the NRE/NRO account.

The refund amount will be paid through Electronic Transfer to their bank account.

The following are the reasons for the failure of the transaction –

1. Mismatch in filled Account Details: Wrong Account No.; Wrong IFSC Code; etc

2. Dormant/Freeze account due to banking reasons

The online module for the refund process started on December 22, 2023, till 02.00 pm on December 28, 2023. If any mistake is found in the details of the refund, then report ACPUGMEC through the following e-mail: medadmgujarat2018@gmail.com.

The list of unsuccessful tuition fee refund and security deposit refund candidates list of round 3, and the list of successful candidates whose tuition fee and security deposit have been refunded for rounds 1, 2, and 3 have also been released.

To view the notices, click on the links below –

https://medicaldialogues.in/pdf_upload/medical-returnfinal-228558.pdf

https://medicaldialogues.in/pdf_upload/instructions-for-refund-round-4-ug-2023-24-228557.pdf

https://medicaldialogues.in/pdf_upload/successful-ug-security-deposite-refund-2-228559.pdf

https://medicaldialogues.in/pdf_upload/successful-ug-security-deposite-refund-3-228560.pdf

https://medicaldialogues.in/pdf_upload/successful-ug-tuition-fee-refund-2-228561.pdf

https://medicaldialogues.in/pdf_upload/successful-ug-tuition-fee-refund-3-228562.pdf

https://medicaldialogues.in/pdf_upload/ugr1successful-228563.pdf

https://medicaldialogues.in/pdf_upload/unsuccessful-ug-security-deposite-refund-3-228564.pdf

https://medicaldialogues.in/pdf_upload/unsuccessful-ug-tuition-fee-refund-3-228565.pdf

Powered by WPeMatico

Disclosure of Assets of Members: NMC Expresses its Reservations to Health Ministry

New Delhi: Amid the rising pressure to make the details of the assets and liabilities of the NMC Chairman and members public, the National Medical Commission (NMC) has expressed its ‘reservations’ in this regard.

Writing to the Under Secretary of the Union Ministry of Health and Family Welfare (MoHFW), the Commission has mentioned about the reservations for uploading some of the personal information of the officers including the details of lands, jewellery, investments in banks/ financial institutions/ insurance policy i.e. numbers, addresses etc.

Urging the Ministry to review the prescribed forms mentioned in the National Medical Commission Act, 2019, the Commission has further requested it to furnish its decision on the matter on an urgent basis.

This comes after the pending issue of asset disclosure was raised by Kannur-based Health Activist Dr. KV Babu, who filed a Right to Information (RTI) application in this regard to the Prime Minister’s Office. Consequently, the PMO directed the Union Health Ministry to take “appropriate action” in this regard. Apart from directing the Union Health Ministry to take action, the PMO also forwarded the complaint on non-disclosure of assets by the NMC members.

Also Read: NMC Disclosure of Assets: PMO Forwards Issue to Health Ministry for Appropriate Action

NMC Act 2019 on Asset Disclosure: 

The Chairperson and every member of NMC must declare their assets and liabilities at the time of entering the office and at the time of emitting it, mention the rules.

In this regard, Section 6(6) of the NMC Act 2019 States, “The Chairperson and every member of the Commission shall make declaration of his assets and his liabilities at the time of entering upon his office and at the time of demitting his office and also declare his professional and commercial engagement or involvement in such form and manner as may be prescribed, and such declaration shall be published on the website of the Commission.”

The Issue: 

Medical Dialogues had earlier reported that alleging a lack of transparency in the functioning of the Commission, RTI activist Dr. Babu KV had previously filed several applications under the Right to Information (RTI) Act.

The first application was filed on April 6 and referring to Section 6(6) of the NMC Act 2019, Dr. Babu sought the details of disclosure by the Chairman and members of NMC along with the details of disclosure by those who demitted NMC. Later, he also filed several other applications. However, he did not receive any response from the Commission.

Thereafter, he wrote a letter to the Union Health Minister Mansukh Mandaviya on July 12 seeking response. Dr. Babu pointed out that NMC was violating the NMC Act and RTI Act 2005 and therefore, he urged the Union Health Ministry to invoke section 45 of the NMC Act 2019 and direct the Commission to comply with NMC Act 6(6) and disclose the assets and liabilities without any delay.

Also Read :Pressure on NMC, Health Ministry for asset disclosure of NMC members

Dr. Babu informed that he filed two more RTI applications on July 19 and September 12. On both occasions, he was informed that as per the records available in the MEI section, no such e-mail related to non-disclosure of the assets/liabilities of NMC members had been received.

Thereafter, Dr. Babu wrote to the PMO on October 16, 2023, and filed an RTI application on October 24, 2023. Consequently, he received an RTI Reply on 09.11.2023 mentioning that his application was forwarded to the Health Ministry.

NMC Letter to Health Ministry: 

Following this, the NMC has now written to the Union Health Ministry on December 12, 2023, and expressed its reservation regarding the demand for making the documents public.

In the letter, a copy of which is with the Medical Dialogues team, the Commission referred to the grievance received on 23.10.2023 from Dr. Babu K.V. and the State note of NMC dated 09.06.2023.

Referring to the para (5) of the said status Note, NMC mentioned in the letter, “With regard to uploading of the said Forms in NMC’s website, there has been reservations for uploading some personal information of the officers, as prescribed in the Forms given in the said Rules in the public domain like complete details of lands, jewellery, investments in banks/ financial institutions/ insurance policy i.e. numbers, addresses etc. In view of the above concerns, it is requested to review the prescribed Forms given in the said Rules.”

At this outset, NMC requested the Union Health Ministry to review the prescribed forms mentioned in the NMC Act. 2019 and furnish its decision on the matter on urgent basis. The Commission further urged the Ministry to convey its decision at the earliest in case it is felt that NMC has to go ahead and upload the forms, so that needful may be done by the Commission.

Commenting on the matter, Dr. Babu told Medical Dialogues, “Even though it is mandatory for the NMC members to disclose their assets, NMC did nothing in this regard until after my RTI was filed. They have waited for two and a half years. They should have done it earlier. This is the statute.”

He further added, “NMC sent a communication in this regard on 9th June to the Ministry of Health. However, they remained silent on the matter afterward and it remained pending for 6 months. NMC never asked the Minister of Health what to do. It is around 2 months after my complaint to the PMO on 16th October, NMC is writing to the Ministry on 12th of December. They remained silent till my complaint to the PMO. It clearly shows that they were sabotaging the process of asset disclosure on the website.”

“I am hopeful that there will now be an action after the involvement of the PMO. As per the letter dated December 12, some of the officers have objected to making it public, If there is any objection, they should relinquish their posts,” he mentioned.

When asked why NMC members must make these documents public, he added, “Removal of MCI was following the allegations of corruptions. The parliamentary committee report was also critical of the MCI functioning and alleged that it was not transparent. NMC cannot go the MCI way again. They have to be transparent. That is why it has been made a part of the statute itself.”

Also Read: NMC refuses to disclose Details Of Assets and liabilities of its members, RTI unanswered

Powered by WPeMatico